Protective effect of quercetin on the morphology of pancreatic β-cells of streptozotocin-treated diabetic rats

African Journal of Traditional, Complementary and Alternative Medicines

Volumn 4, Issue 1, 2007, Pages 64-74

  Adewole, Stephen O ^a   Caxton Martins, Ezekiel A ^a   Ojewole, John A O ^b  

^a OBAFEMI AWOLOWO UNIVERSITY   (Nigeria)

^b University of KwaZulu Natal Faculty of Health Sciences   (South Africa)

Author keywords

Antioxidant enzymes; Pancreatic cell; Quercetin; Streptozotocin

Indexed keywords

CATALASE; CITRIC ACID; GLUCOSE; GLUTATHIONE PEROXIDASE; INSULIN; MALONALDEHYDE; NITRIC OXIDE; QUERCETIN; STREPTOZOCIN; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CELL PROTECTION; CELL STRUCTURE; CELL VIABILITY; CHROMATIN STRUCTURE; CONTROLLED STUDY; CYTOLYSIS; CYTOPLASM; DIABETES MELLITUS; ENZYME ACTIVITY; FEMALE; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; RAT; STATISTICAL SIGNIFICANCE; STREPTOZOCIN DIABETES; TEST STRIP;

EID: 33846353847     PISSN: 01896016     EISSN: 01896016     Source Type: Journal    
DOI: 10.4314/ajtcam.v4i1.31196     Document Type: Article

References (68)

1. Bach, J. F. (1994). Insulin-dependent diabetes mellitus as an autoimmune disease. Endicr. Rev., 15: 516-542.
2. Baynes, J. W. (1991). Role of oxidative stress in the development of complications in diabetes. Diabetes, 40: 405-412.
3. Bernard-Kargar, C. and Ktorza, A. (2001). Endocrine pancreas plasticity under physiological and pathological conditions. Diabetes, 50: 30S-35S.
4. Bronner, C. and Landry, Y. (1985). Kinetics of inhibitory effect of flavonoids on histamine secretion from mast cells. Agents Action, 16: 147-151.
5. Butler, E. A., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., and Butler P. C. (2003). Beta-cell deficit and increased β-cell apoptosis in humans with type2 diabetes. Diabates, 52: 102-110.
6. Chang, W. S., Lee, Y. J., Lu, F. J. and Chiang, H. C. (1993). Inhibitory effects of flavonoids on xanthine oxidase. Anticancer Res., 13: 2165-2170.
7. Chaudry, P. S., Cabera, J., Juliann, H. R. and Varma, S. D. (1983). Inhibition of human lens aldose reductase by flavonoids, sulindac, and indomethacin. Biochem. Pharmacol., 32: 1995-1998.
8. Chen, Y. T., Zheng, R. L., Jia, Z. J., and Ju, Y. (1990). Flavonoids as superoxide scavengers and antioxidants. Free Radic. Biol. Med., 9: 19-20.
9. Corbbet, J. A., Sweetland, M. A., Wang, J. L., Lancaster, J. R. and McDaniel, M. L. (1993). Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans. Proc. Natl. Acad. Sci. (USA), 90: 1731-1735.
10. Cox, D., Whichelow, M. J. and Prevost, T. A. (2000). Antioxidant effects of flavonoids: Public Health Nutr., 3: 19-29.
11. De la Fuente, M. and Victor, V. M. (2000). Antioxidants as modulator of immune functions. Immunol. Cell Biol., 78: 49-54.
12. Della-Logia, A., Ragazzi, E. and Tubaro, et al., (1988). Anti-inflammatory activity of benzopyrones that are inhibitors of cyclo-and lipo-oxygenases. Pharmacol. Res. Commun., 20: 91S-94S.
13. Derouich, M. and Boutayeb, A. (2002). The effect of physical exercise on the dynamics of glucose and insulin. J. Biochem., 35: 911-917.
14. Desbuquois, B. and Aurbach, G. D. (1971). Use of polythene glycol to separate free and antibody-bound peptide hormones in radioimmunoassay. Clin. Endocrinol. Metab., 37: 732-738.
15. DeWhalley, C. V., Rankin, J. F. and Rankin, S. M. et al., (1990). Flavonoids inhibit oxidative modification of low density lipoproteins. Biochem. Pharmacol., 39: 1734-1749.
16. Donath, M. Y., Gross, D. J., Cerasi, E. and Kaiser, N. (1999). Hyperglycemia-induced β-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes. Diabetes, 48: 738-744.
17. Dong, H., Anthony, K. and Morral, N. (2002). Challenges for gene therapy of type 1 diabetes. Curr. Gene Ther., 2: 403-414.
18. Dumontet, C., Drai, J., Thieblemont, C., Hequet, O., Espinouse, D., Bouafia, F., Salles, G. and Coiffier, B. (2001). The superoxide dismutase content in erythrocytes predicts short-term toxicity of high-dose cyclophosphamide. Br. J. Haematol., 112: 405-409.
19. Flohe, L. and Otting, F. (1984). Superoxide dismutase assays. Methods Enzymol., 105: 93-104.
20. Fox, C. C., Wolf, E. J., Kagey-Sobotka, A. and Lichtenstein, L. M. (1988). Comparison of human lung and intestinal mast cells. J. Allergy Clin. Immunol., 81: 89-94.
21. Gadot, M., Ariav, Y., Cerasi, E., Kaiser, N. and Gross, D. (1995). Hyper-proinsulinemia in the diabetic Psammomys obesus is a result of increased secretory demand on the β-cell. Endocrinology, 136: 4218-4223.
22. Goodyear, L. J. and Kahn, B. B. (1998). Exercise, glucose tolerance, and insulin sensitivity. Ann. Rev. Med., 49: 235-261.
23. Grankvist, K., Marklund, S. L. and Taljedal, L. B. (1981). CuZn-superoxide dismutase, Mn-superoxide dismutase, catalase and glutathione peroxidase in the mouse. Biochem. J., 199: 393-398.
24. 15N] nitrate in biological fluids. Anal. Biochem., 126: 131-138.
25. Gul, M., Laaksonen, D. E., Atalay, M., Vider, L. and Hannien, O. (2002). Effects of endurance training on tissue glutathione homoestasis and lipid peroxidation in streptozotocin-induced diabetic rats. Scand. J. Med. Sci. Sports, 12: 163-170.
26. Gutteridge, J. M. and Halliwell, B. (1990). The measurement and mechanism of lipid peroxidation in biological systems. Trends Biochem Sci., 15: 129-135.
27. Halliwell, B. and Gutteridge, J. M. (1989). Free Radicals in Biology and Medicine. 2nd ed., Oxford: Clarendon Press.
28. Hammers, H. D., Martin, S., Fedesrlin, K., Geisen, K. and Bowler, M. (1991). Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. Proc. Natl. Acad. Sci. (USA), 88: 11555-11558.
29. Henriksen, E. J. (2002). Invited review: Effects of acute exercise and exercise training on insulin resistance. J. Appl. Physiol., 93: 788-796.
30. Henry, J. D. (1984). Clinical diagnosis and management by laboratory methods. 17th ED., p.1433.
31. Hertog, M. G. L. and Hollman, P. C. H. (1996). Potential health effects of the dietary flavonol quercetin. Eur. J. Clin. Nutr., 50: 63-71.
32. Hunt, J. V., Smith, C. C. and Wolff, S. P. (1990). Autoxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose. Diabetes, 39: 1420-1424.
33. Jacob, R. A. and Burri, B. J. (1996). Oxidative damage and defense. Am. J. Clin. Nutr., 63: 985S-990S.
34. Johansson, L. H. and Borg, L. A. (1988). A spectrophotometric method for determination of catalase activity in small tissue samples. Anal Biochem., 174: 331-336.
35. Jorns, A., Tiedge, M., Ziv, E., Shafrir, E. and Lenzen, S. (2002). Gradual loss of pancreatic β-cell insulin, glucokinase and GLUT2 glucose transporter immunoreactivities during the time-course of nutritionally-induced type 2 diabetes in Psammomys obesus (sand rat). Virchows Arch, 440: 63-69.
36. 4-treated rats. J. Vet. Med. Physiol. Pathol. Clin. Med., 50: 264-268.
37. Kanter, M., Meral, I., Yener, Z., Ozbek, H. and Demir, H. (2003b). Partial regeneration/proliferation of β-cells in the islets of Langerhans by Nigella sativa Linn. in streptozotocin-induced diabetic rats. Tohoku J. Exp. Med., 201: 213-219.
38. Kaiser, N., Leibowitz, G. and Nesher, R. (2003). Glucotoxicity and β-cell failure in type 2 diabetes mellitus. J. Pediat. Endocrinol. Metab., 16: 5-22.
39. Kloppel, G., Lohr, M., Hablich, K., Oberhilzer, M. and Heinz, P. U. (1985). Islet pathology and pathogenesis of type 1 and type 2 diabetes revisited. Surv. Synth. Pathol. Res., 4: 110-125.
40. Kekow, J., Ulrichs, K., Muller-Ruchholtz, W. and Gross, W. L. (1988). Measurement of rat's insulin: enzyme-linked immunosorbent assay with increased sensitivity, high accuracy, and greater practicability than established radioimmunoassay. Diabetes, 37: 321P.
41. Kim, H. P., Mani, I. and Ziboh, V. A. (1998). Effects of naturally-occuring flavonoids and bio-flavonoids on epidermal cyclooxygenase from guinea-pigs. Prostaglandins Leukot. Essent. Fatty Acids, 58: 17-24.
42. Kröncke, K. D., Fehsel, K., Sommer, A., Rodriguez, M. L. and Kolb-Bachofen, V. (1995). Nitric oxide generation during cellular metabolization of the diabetogenic N-methyl-nitroso-urea: Streptozotocin contributes to islet cell DNA damage. Biol. Chem. Hoppe-Seyler, 376: 179-185.
43. Larocca, L. M., Teofili, L., and Sica, S et al., (1995). Quercetin inhibits the growth of leukemic progenitors and induces the expression of transforming growth factor-B1 in these cells. Blood, 85: 3654-3661.
44. Matkovics, B., Kotorman, M., Varga, I. S., Hai, D. Q. and Varga C. (1998). Oxidative stress in experimental diabetes induced by streptozotocin. Acta Physiol. Hung., 85: 29-38.
45. Matsuoka, T., Kajimoto, Y., Watada, H., Kaneto, H., Kishimoto, M., Umayahara, Y., Fujitani, Y., Kamada, T., Kawamori, R. and Yamasaki, Y. (1998). Glycation-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells. J. Clin. Invest., 99: 144-150.
46. Merzouk, H., Madani, S., Chabane, D., Prost, J., Bouchenak, M. and Belleville, J. (2000). Time-course of changes in serum glucose, insulin, lipids and tissue lipase activities in macrosomic offspring of rats with streptozotocin-induced diabetes. Clin. Sci., 98: 21-30.
47. Miller, A. L. (1996). Antioxidant flavonoids: structure, function and clinical usage. Alt. Med. Rev., 1: 103-111.
48. Moncada, S., Polmer, R. M. J. and Higgs, E. A. (1991). Nitric Oxide: physiology, pathophysiology, and pharmacology. Pharm. Rev., 43: 109-142.
49. Mowry, R. W., Longley, J. B., and Emmel, V. M. (1980). Only aldehyde fuchsin made from pararosanilin stains pancreatic granules and elastic fibers in unoxidized microsections: problems caused by unlabelling of certain basic fuchsins. Stain Technol., 55: 91-103.
50. Nadler, J. L. and Winter, L. (1996). Free radicals, nitric oxide and diabetic complications. In: 'Diabetes Mellitus', edited by D.L.E. Roith, S.I. Taylor and J.M. Olefsky, Lippincott-Raven Publishers, Philadelphia, pp. 840-847.
51. Ohkawa, H., Ohishi, N. and Yagi, K. (1979). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem., 95: 351-358
52. Richelle, M., Turini, M. E., Guidoux, R., Tavazzi, I., Metairon, S. and Fay, L. B. (1999). Urinary isoprostane excretion is not confounded by the lipid content of the diet. FEBS Lett., 459: 259-262.
53. Rossini, A. A., Williams, R. M., Appel, M. C. and Like, A. A. (1978). Complete protection from low-dose streptozotocin-induced diabetes in mice. Nature, 276: 182-184.
54. Saija, A., Scalese, M. and Lanza, M., et al., (1995). Flavonoids as antioxidant agents: importance of their interaction with biomembranes. Free Radic Biol. Med. 19: 481-486.
55. Sakurai, T. and Tsuchiya, S. (1998). Superoxide production from non-enzymatically-glycated protein. FEBS Lett., 236: 406-410.
56. Sies, H. (1997). Oxidative stress: oxidants and antioxidants. Expt. Physiol., 82: 291-295.
57. Slater, T. F. (1984). Free-radical mechanisms in tissue injury. Biochem. J., 222: 1-15.
58. Stavric, B. (1994). Quercetin in our diet: from potent mutagen to probable anticarcinogen. Clin. Biochem., 27:245P.
59. Stephen-Cole, L. (1998). Quercetin: A review of clinical applications, Clin. Sci., 40: 234-238.
60. Tappel, A. L. (1978). Glutathione peroxidase and hydroperoxides. Methods Enzymol., 52: 506-513.
61. Tiedge, M. Lortz, S. Drinkgern, J. Lenzen, S. (1997). Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes; 46:1733-1742.
62. Uchigata, Y., Yamamoto, H., Kawamura, A. and Okamoto, H. (1982). Protection by superoxide dismutase, catalase and poly (ADP-ribose) sunthetase inhibitors against alloxan-and streptozotocin-induced islet DNA strand breaks and against the inhibition of proinsulin synthesis. J. Biol. Chem., 257: 6084-6088.
63. UK Prospective Diabetes Study (UKPDS) Group (1998). Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837-853.
64. Weyer, C., Bogardus, C., Mott, D. M. and Pratley, R. E. (1999). The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J. Clin. Invest., 104: 787-794.
65. Weiss, R. B. (1982). Streptozotocin: a review of it pharmacology, efficacy and toxicity. Cancer Treat. Rep., 66: 427-438.
66. World Health Organization. (1985). Report of a WHO study Group. Geneva, World Health Org. Diabetes Mellitus. Tech. Rep. Ser., No. 727.
67. World Health Organization. (1999). Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications: Part I: diagnosis and classification of diabetes. Geneva WHO/NCD/NCS 99(2), pp. 1-58.
68. Zima, T., Fialova, L., Kestek, O., Janebova, M., Crkovska, J., Malbohan, I., Stipek, S., Mikulikova, L. and Popov, P. (2001). Hepatic injury: antecedent of oxidative stress. J. Biomed. Sci., 8: 59-70.